264 related articles for article (PubMed ID: 29848401)
41. Reticulocyte-binding protein homologue 5 - an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum.
Baum J; Chen L; Healer J; Lopaticki S; Boyle M; Triglia T; Ehlgen F; Ralph SA; Beeson JG; Cowman AF
Int J Parasitol; 2009 Feb; 39(3):371-80. PubMed ID: 19000690
[TBL] [Abstract][Full Text] [Related]
42. Plasmodium falciparum field isolates from South America use an atypical red blood cell invasion pathway associated with invasion ligand polymorphisms.
Lopez-Perez M; Villasis E; Machado RL; Póvoa MM; Vinetz JM; Blair S; Gamboa D; Lustigman S
PLoS One; 2012; 7(10):e47913. PubMed ID: 23118907
[TBL] [Abstract][Full Text] [Related]
43. Evidence for multiple B- and T-cell epitopes in Plasmodium falciparum liver-stage antigen 3.
Toure-Balde A; Perlaza BL; Sauzet JP; Ndiaye M; Aribot G; Tall A; Sokhna C; Rogier C; Corradin G; Roussilhon C; Druilhe P
Infect Immun; 2009 Mar; 77(3):1189-96. PubMed ID: 19139199
[TBL] [Abstract][Full Text] [Related]
44. Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies.
Willcox AC; Huber AS; Diouf A; Barrett JR; Silk SE; Pulido D; King LDW; Alanine DGW; Minassian AM; Diakite M; Draper SJ; Long CA; Miura K
Cell Rep Med; 2021 Jul; 2(7):100326. PubMed ID: 34337556
[TBL] [Abstract][Full Text] [Related]
45. Strain-Dependent Inhibition of Erythrocyte Invasion by Monoclonal Antibodies Against
Knudsen AS; Björnsson KH; Bassi MR; Walker MR; Kok A; Cristinoi B; Jensen AR; Barfod L
Front Immunol; 2021; 12():716305. PubMed ID: 34447381
[TBL] [Abstract][Full Text] [Related]
46. Characterization of conserved T- and B-cell epitopes in Plasmodium falciparum major merozoite surface protein 1.
Parra M; Hui G; Johnson AH; Berzofsky JA; Roberts T; Quakyi IA; Taylor DW
Infect Immun; 2000 May; 68(5):2685-91. PubMed ID: 10768960
[TBL] [Abstract][Full Text] [Related]
47. Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum.
Barry AE; Schultz L; Buckee CO; Reeder JC
PLoS One; 2009 Dec; 4(12):e8497. PubMed ID: 20041125
[TBL] [Abstract][Full Text] [Related]
48. Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development.
Takala SL; Coulibaly D; Thera MA; Batchelor AH; Cummings MP; Escalante AA; Ouattara A; Traoré K; Niangaly A; Djimdé AA; Doumbo OK; Plowe CV
Sci Transl Med; 2009 Oct; 1(2):2ra5. PubMed ID: 20165550
[TBL] [Abstract][Full Text] [Related]
49. Geographical patterns of allelic diversity in the Plasmodium falciparum malaria-vaccine candidate, merozoite surface protein-2.
Hoffmann EH; da Silveira LA; Tonhosolo R; Pereira FJ; Ribeiro WL; Tonon AP; Kawamoto F; Ferreira MU
Ann Trop Med Parasitol; 2001 Mar; 95(2):117-32. PubMed ID: 11299119
[TBL] [Abstract][Full Text] [Related]
50. Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes.
Healer J; Wong W; Thompson JK; He W; Birkinshaw RW; Miura K; Long CA; Soroka V; Søgaard TMM; Jørgensen T; de Jongh WA; Weir C; Svahn E; Czabotar PE; Tham WH; Mueller I; Barlow PN; Cowman AF
Cell Microbiol; 2019 Jul; 21(7):e13030. PubMed ID: 30965383
[TBL] [Abstract][Full Text] [Related]
51. Resurrection of the ancestral RH5 invasion ligand provides a molecular explanation for the origin of P. falciparum malaria in humans.
Galaway F; Yu R; Constantinou A; Prugnolle F; Wright GJ
PLoS Biol; 2019 Oct; 17(10):e3000490. PubMed ID: 31613878
[TBL] [Abstract][Full Text] [Related]
52. PfRH5 as a candidate vaccine for Plasmodium falciparum malaria.
Drew DR; Beeson JG
Trends Parasitol; 2015 Mar; 31(3):87-8. PubMed ID: 25704640
[TBL] [Abstract][Full Text] [Related]
53. Research note: HLA degenerate T-cell epitopes from Plasmodium falciparum liver stage-specific antigen 1 (LSA-1) are highly conserved in isolates from geographically distinct areas.
Ravichandran M; Doolan DL; Cox-Singh J; Hoffman SL; Singh B
Parasite Immunol; 2000 Sep; 22(9):469-73. PubMed ID: 10972854
[TBL] [Abstract][Full Text] [Related]
54. Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen.
Dreyer AM; Matile H; Papastogiannidis P; Kamber J; Favuzza P; Voss TS; Wittlin S; Pluschke G
J Immunol; 2012 Jun; 188(12):6225-37. PubMed ID: 22593616
[TBL] [Abstract][Full Text] [Related]
55. Genetic diversity and natural selection on the thrombospondin-related adhesive protein (TRAP) gene of Plasmodium falciparum on Bioko Island, Equatorial Guinea and global comparative analysis.
Lin LY; Huang HY; Liang XY; Xie DD; Chen JT; Wei HG; Huang WY; Ehapo CS; Eyi UM; Li J; Wang JL; Zheng YZ; Zha GC; Wang YL; Chen WZ; Liu XZ; Mo HT; Chen XY; Lin M
Malar J; 2021 Mar; 20(1):124. PubMed ID: 33653360
[TBL] [Abstract][Full Text] [Related]
56. In-silico structural modeling and epitope prediction of highly conserved Plasmodium falciparum protein AMR1.
Sanasam BD; Kumar S
Mol Immunol; 2019 Dec; 116():131-139. PubMed ID: 31648168
[TBL] [Abstract][Full Text] [Related]
57. Genetic diversity of vaccine candidate antigens in Plasmodium falciparum isolates from the Amazon basin of Peru.
Chenet SM; Branch OH; Escalante AA; Lucas CM; Bacon DJ
Malar J; 2008 May; 7():93. PubMed ID: 18505558
[TBL] [Abstract][Full Text] [Related]
58. Assessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS,S leading malaria vaccine candidate.
Mohamed NS; AbdElbagi H; Elsadig AR; Ahmed AE; Mohammed YO; Elssir LT; Elnour MB; Ali Y; Ali MS; Altahir O; Abubakr M; Siddig EE; Ahmed A; Omer RA
Malar J; 2021 Nov; 20(1):436. PubMed ID: 34758827
[TBL] [Abstract][Full Text] [Related]
59. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
60. A single amino acid change in the Plasmodium falciparum RH5 (PfRH5) human RBC binding sequence modifies its structure and determines species-specific binding activity.
Arévalo-Pinzón G; Curtidor H; Muñoz M; Patarroyo MA; Bermudez A; Patarroyo ME
Vaccine; 2012 Jan; 30(3):637-46. PubMed ID: 22100885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
